Most patients with myeloma combined with pneumonia can be cured of the infection after active anti-infection and immunity-enhancing treatment. Very few patients develop sepsis with infectious toxic shock and multiple organ failure, and the survival period is very short.
Myeloma patients themselves are tumor diseases, and tumor cells secrete a large number of abnormal immunoglobulin, which interferes with the normal anti-infection ability. Coupled with chemotherapy and other treatments, the body’s immune function is even lower, and it is easy to be infected with lung inflammation. It is recommended to actively target the myeloma itself and reduce the tumor load in time in order to fundamentally improve the body’s immune ability.
Once pneumonia occurs, active anti-infection treatment is needed to save life.
Before treatment, chest CT, blood bacterial and fungal culture, sputum bacterial and fungal culture and other tests are needed to clarify the site of infection and the causative agent. In order to avoid delaying the disease, antibiotics should be selected empirically to provide vigorous anti-infective treatment, and sensitive antibiotics, including anti-bacterial, anti-fungal, anti-viral, and anti-tuberculosis, should be adjusted according to the situation after the sputum culture results are returned.
If the infection worsens and bacteria enter the bloodstream to form sepsis or septicemia, it is necessary to increase the level of antibiotics, in addition to the use of gammaglobulin and other immune enhancement to strengthen the effect of anti-infection. If there is hypoproteinemia, albumin supplementation is also needed.
If myeloma patients have lung inflammation, it is recommended to seek timely medical treatment, active treatment, drugs need to be used under the guidance of a doctor.